Corporate News     14-Dec-22
Biocon initiates clinical study of Itolizumab for Ulcerative Colitis in India
Biocon announced the initiation of the clinical study of Itolizumab in patients with Ulcerative Colitis (UC) in India, in collaboration with Equillium Inc. This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled (adalimumab), two treatment period study to evaluate the safety and efficacy of Itolizumab for the induction of remission in biologics naïve patients with moderate to severely active UC.

Having obtained approval from the Drugs Controller General of India (DCGI), the study will cover several tertiary hospitals specialized in handling UC cases. The first patient who intended to participate in the study was screened on 01 December 2022.

Previous News
  Biocon consolidated net profit declines 29.78% in the June 2023 quarter
 ( Results - Announcements 11-Aug-23   07:47 )
  Biocon
 ( Results - Analysis 17-May-24   10:41 )
  Biocon rallies after recording PAT of Rs 126 cr in Q2 FY24
 ( Hot Pursuit - 12-Nov-23   18:17 )
  Biocon Biologics strengthens its leadership team
 ( Corporate News - 04-Aug-23   16:05 )
  Biocon edges higher after obtaining UK MHRA nod for diabetes drug Liraglutide
 ( Hot Pursuit - 28-Mar-24   10:06 )
  Biocon signs exclusive licensing and supply agreement with Handok
 ( Corporate News - 24-May-24   09:06 )
  Biocon Biologics appoints Shreehas Tambe as MD, CEO
 ( Hot Pursuit - 05-Dec-22   15:07 )
  Biocon Ltd down for fifth straight session
 ( Hot Pursuit - 17-Jun-22   13:35 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 29-Sep-23   13:05 )
  Biocon initiates clinical study of Itolizumab for Ulcerative Colitis in India
 ( Corporate News - 14-Dec-22   19:23 )
  Mahindra Lifespace Developers Ltd leads losers in 'A' group
 ( Hot Pursuit - 28-Jul-22   15:00 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top